The Patent Finder

Maintenance fees coming due

Aldeyra Therapeutics, Inc.

10 maintenance fees come due in the 12 months from Nov 21, 2026, the next on Jan 18, 2027. Unpaid by Jul 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,701,331Toxic Aldehyde Related Diseases and Treatment
In force
Fee due Jan 18, 2027
Lapses if unpaid Jul 19, 2027
 · Medium confidence
Aldeyra Therapeutics, Inc.In forceJan 18, 2027Jul 19, 2027Medium confidence
US 10,414,732Polymorphic Compounds and Uses Thereof
In force
Fee due Mar 17, 2027
Lapses if unpaid Sep 17, 2027
 · High confidence
Aldeyra Therapeutics, Inc.In forceMar 17, 2027Sep 17, 2027High confidence
US 10,426,790Treatment of Allergic Eye Conditions with Cyclodextrins
In force
Fee due Apr 1, 2027
Lapses if unpaid Oct 1, 2027
 · High confidence
Aldeyra Therapeutics, Inc.In forceApr 1, 2027Oct 1, 2027High confidence
US 11,771,664Toxic Aldehyde Related Diseases and Treatment
In force
Fee due Apr 3, 2027
Lapses if unpaid Oct 4, 2027
 · Medium confidence
Aldeyra Therapeutics, Inc.In forceApr 3, 2027Oct 4, 2027Medium confidence
US 11,786,518Ophthalmic Formulations and Uses Thereof
In force
Fee due Apr 17, 2027
Lapses if unpaid Oct 18, 2027
 · High confidence
Aldeyra Therapeutics, Inc.In forceApr 17, 2027Oct 18, 2027High confidence
US 11,845,722Deuterated Compounds and Uses Thereof
In force
Fee due Jun 19, 2027
Lapses if unpaid Dec 20, 2027
 · High confidence
Aldeyra Therapeutics, Inc.In forceJun 19, 2027Dec 20, 2027High confidence
US 10,543,181Toxic Aldehyde Related Diseases and Treatment
In force
Fee due Jul 28, 2027
Lapses if unpaid Jan 28, 2028
 · High confidence
Aldeyra Therapeutics, Inc.In forceJul 28, 2027Jan 28, 2028High confidence
US 10,550,085Deuterated Compounds and Uses Thereof
In force
Fee due Aug 4, 2027
Lapses if unpaid Feb 4, 2028
 · High confidence
Aldeyra Therapeutics, Inc.In forceAug 4, 2027Feb 4, 2028High confidence
US 11,911,385Methotrexate Treatment Methods
In force
Fee due Aug 27, 2027
Lapses if unpaid Feb 28, 2028
 · High confidence
Aldeyra Therapeutics, Inc.In forceAug 27, 2027Feb 28, 2028High confidence
US 10,588,874Toxic Aldehyde Related Diseases and Treatment
In force
Fee due Sep 17, 2027
Lapses if unpaid Mar 17, 2028
 · Medium confidence
Aldeyra Therapeutics, Inc.In forceSep 17, 2027Mar 17, 2028Medium confidence
10 of 10 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited